halfgeleider studie attribuut atacicept mechanism of action België Bijwerken Surrey Onvermijdelijk
Atacicept in relapsed/refractory multiple myeloma or active Waldenström's macroglobulinemia: a phase I study | British Journal of Cancer
Mechanism of action of Pis, immunomodulators, and HDACi. Notes:... | Download Scientific Diagram
Frontiers | Treatment-Induced BAFF Expression and B Cell Biology in Multiple Sclerosis | Immunology
Clinical Pharmacokinetics and Pharmacodynamics of Biologic Therapeutics for Treatment of Systemic Lupus Erythematosus. - Abstract - Europe PMC
Mechanisms of action and historical facts on the use of intravenous immunoglobulins in systemic lupus erythematosus - ScienceDirect
Mechanisms of action for human B-cell activating factor and a... | Download Scientific Diagram
Mechanisms of action of rituximab (reproduced from Dierickx et al 24... | Download Scientific Diagram
A, expression of the 3 related TNF-R family members BAFF-R, TACI, and... | Download Scientific Diagram
A, expression of the 3 related TNF-R family members BAFF-R, TACI, and... | Download Scientific Diagram
Frontiers | B Cells Are Multifunctional Players in Multiple Sclerosis Pathogenesis: Insights from Therapeutic Interventions | Immunology
PDF) Atacicept in relapsed/refractory multiple myeloma or active Waldenstr??m's macroglobulinemia: A phase I study
Microorganisms | Free Full-Text | Microbiota, IgA and Multiple Sclerosis | HTML
Atacicept in relapsed/refractory multiple myeloma or active Waldenström's macroglobulinemia: a phase I study | British Journal of Cancer
PDF) B cells targeting therapy in the management of systemic lupus erythematosus
Atacicept in patients with rheumatoid arthritis and an inadequate response to tumor necrosis factor antagonist therapy: Results of a phase II, randomized, placebo‐controlled, dose‐finding trial - Genovese - 2011 - Arthritis &
Calaméo - RIB 2016
Mechanism of action of belimumab. B-lymphocyte stimulator (BLyS)... | Download Scientific Diagram
Microorganisms | Free Full-Text | Microbiota, IgA and Multiple Sclerosis | HTML